{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:05:33Z","timestamp":1791140733558,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["261472"],"award-info":[{"award-number":["261472"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["280873"],"award-info":[{"award-number":["280873"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ebiom.2017.07.013","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T14:47:27Z","timestamp":1500130047000},"page":"164-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe"],"prefix":"10.1016","volume":"22","author":[{"given":"Odile","family":"Launay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Anemona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Loulergue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella Silvia","family":"Scir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Zancan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rondini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Marhaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oretta","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Gerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audino","family":"Podda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ebiom.2017.07.013_bb0005","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3201\/eid1611.090934","article-title":"Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia","volume":"16","author":"Bardhan","year":"2010","journal-title":"Emerg. Infect. Dis."},{"issue":"12","key":"10.1016\/j.ebiom.2017.07.013_bb0010","first-page":"318","article-title":"Importation and domestic transmission of Shigella sonnei resistant to ciprofloxacin - United States, May 2014\u2013February 2015","volume":"64","author":"Bowen","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/erv.12.135","article-title":"Recent progress towards development of a Shigella vaccine","volume":"12","author":"Camacho","year":"2013","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/jcm.27.1.162-167.1989","article-title":"Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections","volume":"27","author":"Cohen","year":"1989","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.ebiom.2017.07.013_bb0025","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1128\/jcm.29.2.386-389.1991","article-title":"Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis","volume":"29","author":"Cohen","year":"1991","journal-title":"J. Clin. Microbiol."},{"issue":"9046","key":"10.1016\/j.ebiom.2017.07.013_bb0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2017.07.013_bb0035","first-page":"222","article-title":"The epidemiology of travel-associated shigellosis\u2014regional risks, seasonality and serogroups","volume":"51","author":"Ekdahl","year":"2005","journal-title":"J. Inf. Secur."},{"issue":"6","key":"10.1016\/j.ebiom.2017.07.013_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a116134","article-title":"Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile","volume":"134","author":"Ferreccio","year":"1991","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.ebiom.2017.07.013_bb0045","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/IAI.69.7.4545-4553.2001","article-title":"Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults","volume":"69","author":"Fries","year":"2001","journal-title":"Infect. Immun."},{"issue":"10053","key":"10.1016\/j.ebiom.2017.07.013_bb0050","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ebiom.2017.07.013_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0060","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijantimicag.2012.02.005","article-title":"Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009","volume":"40","author":"Gu","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.ebiom.2017.07.013_bb0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0264-410X(90)90094-3","article-title":"Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease","volume":"8","author":"Herrington","year":"1990","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ebiom.2017.07.013_bb0070","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1586\/14787210.2015.983902","article-title":"Treatment of drug-resistant Shigella infections","volume":"13","author":"Klontz","year":"2015","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"16","key":"10.1016\/j.ebiom.2017.07.013_bb0080","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/0264-410X(95)00102-7","article-title":"A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity","volume":"13","author":"Kotloff","year":"1995","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2017.07.013_bb0085","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull. World Health Organ."},{"issue":"9888","key":"10.1016\/j.ebiom.2017.07.013_bb0090","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ebiom.2017.07.013_bb0095","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/j.carres.2008.09.017","article-title":"The elucidation of the structure of the core part of the LPS from Plesiomonas shigelloides serotype O17 expressing O-polysaccharide chain identical to the Shigella sonnei O-chain","volume":"343","author":"Kubler-Kielb","year":"2008","journal-title":"Carbohydr. Res."},{"issue":"7","key":"10.1016\/j.ebiom.2017.07.013_bb0100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.ebiom.2017.07.013_bb0105","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.02713-12","article-title":"Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries","volume":"51","author":"Lindsay","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.ebiom.2017.07.013_bb0110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S1473-3099(14)70808-4","article-title":"Development and assessment of molecular diagnostic tests for 15 enteropathogens causing childhood diarrhoea: a multicentre study","volume":"14","author":"Liu","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.ebiom.2017.07.013_bb0115","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/cid\/ciu468","article-title":"Shigella isolates from the global enteric multicenter study inform vaccine development","volume":"59","author":"Livio","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"9859","key":"10.1016\/j.ebiom.2017.07.013_bb0120","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2017.07.013_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijmm.2015.12.003","article-title":"Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei generalized modules for membrane antigens (GMMA) reveals highly pure preparations","volume":"306","author":"Maggiore","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"issue":"26","key":"10.1016\/j.ebiom.2017.07.013_bb0130","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.vaccine.2016.02.075","article-title":"Status of vaccine research and development for Shigella","volume":"34","author":"Mani","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2017.07.013_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157385","article-title":"Neutropenia as an adverse event following vaccination: results from randomized clinical trials in healthy adults and systematic review","volume":"11","author":"Muturi-Kioi","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2017.07.013_bb0140","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.vaccine.2009.12.050","article-title":"Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children","volume":"28","author":"Passwell","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-1759(96)00146-9","article-title":"Limiting dilution analysis of virus-specific memory B cells by an ELISPOT assay","volume":"199","author":"Slifka","year":"1996","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.ebiom.2017.07.013_bb0150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.4161\/hv.7.6.15482","article-title":"The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans","volume":"7","author":"Toneatto","year":"2011","journal-title":"Hum. Vaccin."},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clim.2013.03.009","article-title":"Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a","volume":"148","author":"Wahid","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.ebiom.2017.07.013_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","article-title":"Strategies for intranasal delivery of vaccines","volume":"3","author":"Zaman","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"issue":"34","key":"10.1016\/j.ebiom.2017.07.013_bb0165","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2017.07.013_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1994.tb44249.x","article-title":"Molecular and cellular mechanisms of tissue invasion by Shigella flexneri","volume":"730","author":"Zychlinsky","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417302864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417302864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:46:52Z","timestamp":1762454812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396417302864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"alternative-id":["S2352396417302864"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.013","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 GlaxoSmithKline SA. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}